Advances in periodontal diagnosis. 8. Commercial diagnostic kits based on GCF proteolytic and hydrolytic enzyme levels.
Biomarkers of periodontal disease activity may be obtained from potential proteolytic and hydrolytic enzymes of inflammatory cell origin. Commercial diagnostic tests and those under development are discussed along with their advantages and disadvantages.
Eley
B M
BM
Periodontal Department, King's College School of Medicine and Dentistry, London.
Cox
S W
SW
D015415:Biomarkers / Q000032:analysis; D017364:Collagenases / Q000032:analysis; D003546:Cysteine Endopeptidases / Q000032:analysis; D005883:Gingival Crevicular Fluid / Q000201:enzymology*; D005891:Gingivitis / Q000201:enzymology; D005966:Glucuronidase / Q000032:analysis; D006801:Humans; D006867:Hydrolases / Q000032:analysis*; D010196:Pancreatic Elastase / Q000032:analysis; D010447:Peptide Hydrolases / Q000032:analysis*; D010510:Periodontal Diseases / Q000175:diagnosis* / Q000201:enzymology; D011933:Reagent Kits, Diagnostic; D012697:Serine Endopeptidases / Q000032:analysis
D015415:Biomarkers; D011933:Reagent Kits, Diagnostic; D006867:Hydrolases; D005966:Glucuronidase; D010447:Peptide Hydrolases; D012697:Serine Endopeptidases; D010196:Pancreatic Elastase; D003546:Cysteine Endopeptidases; D017364:Collagenases